logo
Study finds stingless bees increase crop yield, quality

Study finds stingless bees increase crop yield, quality

The Hindu27-05-2025
GUWAHATI
A new study has shown that stingless bees, which produce a high-value honey with a distinct flavour, can increase the yield and quality of crops.
Researchers from Nagaland University's Department of Entomology identified Tetragonula iridipennis and Lepidotrigona arcifera, two species of stingless bees, as the most efficient among 11 insect varieties recorded foraging on chilli booms in the open 'under low hill conditions'.
The yield and quality of chilli and other crops increased several times when these stingless bees were introduced as pollinators under greenhouse conditions, the study published in the latest issue of the International Journal of Farm Sciences said.
Entomologists Avinash Chauhan and Imtinaro L. of the university based in Nagaland's Lumami are the authors of the study. Their research over 10 years also yielded methods to minimise losses while rearing stingless bees for quality honey production free from impurities.
'Stingless bees can be used for pollination without fear of being stung. They are known for their popular medicinal honey and pollination potential, which paves the way formulation of crop pollination calendars to benefit all stakeholders. The honey produced by the bees during the experiments also provided extra income besides good crop production,' Dr Chauhan said.
Of the 11 insect species observed on chilli crops 'grown as per good agricultural practices', syrphid flies, houseflies, and stingless bees were found to have foraged the most. The yield and quality parameters under different modes of pollination revealed that bees were superior pollinators.
The researchers found that the fruit set in stingless bee-pollinated king chilli (Capsicum chinense) increased to 29.46% over the non-pollinated crop (21% yield). Similarly, the fruit set in chilli (Capsicum annuum) increased by 7.42% over the non-pollinated crop.
The seed weight, an indicator of viability or germination, also increased by 60.47% when pollinated by the stingless bees.
'We are now working to improve the beekeeping rearing techniques and promote scientific beekeeping with honey bees and stingless bees for better honey production and pollination of crops. The focus is also to raise awareness among the people for the conservation of other wild honey bees and pollinators,' Dr Chauhan said.
The other crops used for the stingless bee pollination test included cucumber, ash gourd, watermelon, tomato, pumpkin, brinjal, and dragon fruit. The potential of these bees as pollinators for fruits such as mango, guava, gooseberry, and Indian jujube was also observed and recorded.
Stingless bees are reported primarily from the northeastern, eastern, and southern Indian States. In the northeast, these bees are reared traditionally in homestead apiaries.
Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

Australian's Foreign Minister Penny Wong announces 34 recipients of Maitri Grants
Australian's Foreign Minister Penny Wong announces 34 recipients of Maitri Grants

India Gazette

time2 hours ago

  • India Gazette

Australian's Foreign Minister Penny Wong announces 34 recipients of Maitri Grants

Canberra [Australia], July 13 (ANI): Australia's Minister of Foreign Affairs Penny Wong has announced 34 recipients of this year's Maitri Grants, Fellowships and Scholarships. The Maitri (meaning friendship) Grants, administered by the Centre for Australia-India Relations, aim to support greater exchange and collaboration with India across technology, business, education and culture, according to the statement. The statement said, 'Each project will cultivate deeper connections between our two countries, including: The Lowy Institute's first-ever India Chair, which will lift the quality of research and conversations around India's role as a major power in the Indo-Pacific region. Best-practice playbooks by Asialink Business to support collaboration, capability training and the sharing of successful partnership models in cleantech and agtech.' 'A world-class exhibition featuring rare artworks by renowned Indian painter Raja Ravi Varma at Queensland Art Gallery | Gallery of Modern Art. An incubator of untold narratives from Australia's South Asian diasporas that will showcase Australian-Indian experience to global screen audiences, led by Bodhi Studios,' it added. The 2024-2025 Maitri Grants include 13 Maitri scholarships supporting innovative research across fields like quantum computing technologies and clean energy solutions, and three Maitri fellowships dedicated to exploring opportunities between Australia. The statement said, 'Australia and India's relationship is closer and more important than ever. We are deepening cooperation across priority sectors that are vital to both nations' futures, including in defence, trade, education, and technology.' The recipients of the 2025 Maitri Grants will support connections and research across a wide range of sectors, including innovation, enterprise, education and culture. Administered by the Centre for Australia-India Relations, the Maitri grants encourageinnovative projects and partnerships that reflect the dynamism of the bilateral relationship, fostering long-term connections, according to the Australian High Commission in India press release. Welcoming the announcement, Australia's High Commissioner to India, Philip Green OAM, said, 'Australia's relationship with India is stronger, deeper and more consequential than ever - and its future holds even greater promise. At the heart of this relationship are the people-to-people connections that bind our two nations. The Maitri Grants program builds on these ties, helping unlock the full potential of our bilateral relationship.' 'I congratulate this year's recipients and look forward to seeing how their work helps foster deeper links between Australia and India,' he added. (ANI)

‘ISRO Averted Axiom-4 Disaster, Ensured Safety Of Shubhanshu Shukla': V Narayanan Reveals How
‘ISRO Averted Axiom-4 Disaster, Ensured Safety Of Shubhanshu Shukla': V Narayanan Reveals How

News18

time2 hours ago

  • News18

‘ISRO Averted Axiom-4 Disaster, Ensured Safety Of Shubhanshu Shukla': V Narayanan Reveals How

Last Updated: ISRO chief V Narayanan said, "On the evening of June 10, we informed SpaceX team to call off the launch. My team was not confident about the rocket's integrity.' Indian Space Research Organisation (ISRO) chief Dr V Narayanan recently revealed that the space agency's decisive stand played a crucial role in the success of Axiom 4, through which Shubhanshu Shukla became the first Indian astronaut to visit the International Space Station (ISS) and the second Indian in orbit after Rakesh Sharma in 1984. The launch, originally scheduled for June 11, was called off on the evening of June 10 after Isro's team detected a leak and later a crack in the Falcon 9 booster. Speaking at the inaugural ceremony of the IEEE International Conference at Presidency University Bengaluru, Narayanan said, he said, 'I was leading the team, and after thorough discussions, we decided not to accept the takeoff. On the evening of June 10, we informed the SpaceX team to call off the launch. My team was not confident about the rocket's integrity and refused to participate." While some dismissed Isro's concerns initially, SpaceX engineers, too, the next day, confirmed the presence of a crack in the Falcon 9 rocket. 'It was a fantastic job of saving the mission," said Narayanan, adding, 'Today, astronaut Shubhanshu Shukla and the entire mission are safe. India is second to none," he said, praising the teamwork that averted potential disaster. Axiom Mission-4 & Shubhanshu Shukla Executed by Axiom Space, in partnership with NASA, ISRO and SpaceX, a four-member crew lifted off aboard a SpaceX Falcon 9 rocket from Launch Complex 39A at NASA's Kennedy Space Center in Florida. The 14-day mission was rescheduled multiple times due to technical issues, including the Falcon 9 leak and problems aboard the ISS. It aimed to conduct major research, including 60 scientific studies and activities representing 31 countries, including the US, India, Poland, Hungary, Saudi Arabia, Brazil, Nigeria, UAE, and nations across Europe. The research will cover space agriculture (e.g. methi, moong daal), tardigrade biology, muscle loss prevention, glucose regulation (Suite Ride diabetes study), cognitive/computer interaction, and more. This will be the most research and science-related activities conducted on an Axiom Space mission aboard the International Space Station to date. These studies include examining muscle regeneration, growth of sprouts and edible microalgae, survival of tiny aquatic organisms, and human interaction with electronic displays in microgravity. The crew will return on July 14. With PTI Inputs view comments First Published: Disclaimer: Comments reflect users' views, not News18's. Please keep discussions respectful and constructive. Abusive, defamatory, or illegal comments will be removed. News18 may disable any comment at its discretion. By posting, you agree to our Terms of Use and Privacy Policy.

Phase-3 clinical trial enrolment for India's first dengue vaccine to be completed by October: ICMR
Phase-3 clinical trial enrolment for India's first dengue vaccine to be completed by October: ICMR

Economic Times

time2 hours ago

  • Economic Times

Phase-3 clinical trial enrolment for India's first dengue vaccine to be completed by October: ICMR

Synopsis India's DengiAll vaccine trial is nearing completion. ICMR scientists anticipate enrolling 10,500 participants by October across 20 Indian centers. The phase III trial assesses the Panacea Biotec's one-shot dengue vaccine. Initial trials showed no safety concerns. Participants will be monitored for two years to evaluate efficacy. This is a crucial step as India currently lacks a licensed dengue vaccine. Agencies Representational image Enrolment of about 10,500 participants in the phase III clinical trial of the indigenous one-shot Panacea Biotec developed dengue vaccine, DengiAll, is likely to be completed by October across 20 centres in India, according to ICMR far, 8,000 participants in various centres at Pune, Chennai, Kolkata, Delhi and Bhubaneswar among others have received either the vaccine or a placebo as part of the trial sponsored by the Indian Council of Medical Research (ICMR) and Panacea Biotec. The trial is co-led by ICMR-National Institute of Translational Virology and AIDS research in Pune, National Institute of Epidemiology (NIE), Chennai and National Institute of Virology, there is no antiviral treatment or licensed vaccine against dengue in results of the Phase-1/2 trial has shown no safety concerns for the one-shot vaccine, NIE Director Dr Manoj Murhekar said. "The participants enrolled in the Phase- III trial will be followed up for two-years. This trial will evaluate the efficacy of this tetravalent dengue vaccine," Dr Murhekar multi-centre, double-blind, randomised, placebo-controlled phase-III trial was launched in August last year to evaluate the jab's efficacy, safety and, long-term immunogenicity. The first participant in this trial was vaccinated at the Pandit Bhagwat Dayal Sharma Post Graduate Institute of Medical Sciences (PGIMS), Rohtak last year. The development of an effective vaccine is complex due to the need to achieve good efficacy for all four serotypes. The dengue virus has four serotypes, 1-4, with low cross-protection against each other, meaning individuals can experience repeated infections, Dr Murhekar said. In India, all four serotypes of dengue virus are known to circulate or co-circulate in many regions. The Union Health Ministry in a statement earlier had said that the tetravalent dengue vaccine strain (TV003/TV005), originally developed by the National Institutes of Health (NIH), USA, has shown promising results in clinical trials in Brazil. Panacea Biotec, one of three Indian companies to receive the strain, is at the most advanced stage of development. The company has worked extensively on these strains to develop a full-fledged vaccine formulation and holds a process patent for this work. Dengue is a major public health concern in India, ranking among the top 30 countries with the highest incidence of the disease. The global incidence of dengue has been steadily increasing over the past two decades, with more than 129 countries reporting dengue viral disease by the end of 2023, according to the World Health Organisation (WHO).In India, approximately 75-80 per cent of infections are asymptomatic, yet these individuals can still transmit the infection through the bite of Aedes mosquitoes. Among the 20-25 per cent of cases where symptoms are clinically apparent, children are at a significantly higher risk of hospitalisation and mortality. In adults, the disease can escalate into severe conditions like dengue hemorrhagic fever and dengue shock syndrome. According to the government data, around 12,043 dengue cases were reported till March this year. In 2024, 2.3 lakh cases and 297 deaths had been recorded.

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into a world of global content with local flavor? Download Daily8 app today from your preferred app store and start exploring.
app-storeplay-store